Paper27445481
Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A.
Castaman G and 1 other. Ther Clin Risk Manag, 2016. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A. Papers, record 27445481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27445481
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References74
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16990605 | A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. | Blood | 2007 | https://conductscience.org/library/papers/16990605 | PubMed |
| 2 | 22428722 | Biological therapies for von Willebrand disease. | Expert Opin Biol Ther | 2012 | https://conductscience.org/library/papers/22428722 | PubMed |
| 3 | 10494765 | Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. | Thromb Haemost | 1999 | https://conductscience.org/library/papers/10494765 | PubMed |
| 4 | 12551832 | Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. | Haematologica | 2003 | https://conductscience.org/library/papers/12551832 | PubMed |
| 5 | 17593277 | International workshop on immune tolerance induction: consensus recommendations. | Haemophilia | 2007 | https://conductscience.org/library/papers/17593277 | PubMed |
| 6 | 17123402 | Recombinant vs. plasma-derived products, especially those with intact VWF, regarding inhibitor development. | Haemophilia | 2006 | https://conductscience.org/library/papers/17123402 | PubMed |
| 7 | 11781224 | Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study. | Blood | 2002 | https://conductscience.org/library/papers/11781224 | PubMed |
| 8 | 18081826 | The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile. | Haemophilia | 2008 | https://conductscience.org/library/papers/18081826 | PubMed |
| 9 | 16985172 | VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors. | Blood | 2007 | https://conductscience.org/library/papers/16985172 | PubMed |
| 10 | 12781551 | Haemophilias A and B. | Lancet | 2003 | https://conductscience.org/library/papers/12781551 | PubMed |
| 11 | 19335752 | Hepatitis A and B immunization for individuals with inherited bleeding disorders. | Haemophilia | 2009 | https://conductscience.org/library/papers/19335752 | PubMed |
| 12 | 19411636 | Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice. | Blood | 2009 | https://conductscience.org/library/papers/19411636 | PubMed |
| 13 | 21649797 | Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A. | Haemophilia | 2011 | https://conductscience.org/library/papers/21649797 | PubMed |
| 14 | 3492222 | Epidemiological investigation of the prevalence of von Willebrand's disease. | Blood | 1987 | https://conductscience.org/library/papers/3492222 | PubMed |
| 15 | 15306670 | Treatment of von Willebrand's Disease. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15306670 | PubMed |
| 16 | 24270421 | von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin αIIbβ3. | J Clin Invest | 2013 | https://conductscience.org/library/papers/24270421 | PubMed |
| 17 | 18175280 | Time to think outside the box? Proposals for a new approach to future pharmacokinetic studies of von Willebrand factor concentrates in people with von Willebrand disease. | Semin Thromb Hemost | 2007 | https://conductscience.org/library/papers/18175280 | PubMed |
| 18 | 18230755 | Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. | Blood | 2008 | https://conductscience.org/library/papers/18230755 | PubMed |
| 19 | 24354480 | Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate. | Haemophilia | 2014 | https://conductscience.org/library/papers/24354480 | PubMed |
| 20 | 17687129 | Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17687129 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39545083 | Hemostats in the clinic. | Bioeng Transl Med | 2024 | https://conductscience.org/library/papers/39545083 | PubMed |
| 37332615 | Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3. | J Blood Med | 2023 | https://conductscience.org/library/papers/37332615 | PubMed |
| 32607039 | Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study). | J Blood Med | 2020 | https://conductscience.org/library/papers/32607039 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| F7 | 2155 | PubTator's text mining | https://conductscience.org/library/genes/2155 | NCBI Gene |
| F8 | 2157 | PubTator's text mining | https://conductscience.org/library/genes/2157 | NCBI Gene |
| FGB | 2244 | PubTator's text mining | https://conductscience.org/library/genes/2244 | NCBI Gene |
| GP1BA | 2811 | PubTator's text mining | https://conductscience.org/library/genes/2811 | NCBI Gene |
| VWF | 7450 | PubTator's text mining | https://conductscience.org/library/genes/7450 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27445481
GET https://conductscience.org/api/papers/v1/27445481/references?page=2